Radiomic profiles are being studied for their potential to improve prognostication and reveal targets for therapy in cancer. Research in this area is exploring the integration of radiomics with other fields such as deep learning, transcriptomics, and metabolomics to better understand cancer biology and improve treatment outcomes. The application of radiomics and artificial intelligence is being investigated in various types of cancer, including cervical cancer, colorectal cancer, and glioblastoma, with potential implications for precision medicine and personalized treatment.